Total intravenous anesthesia with remifentanil, propofol and cisatracurium in end-stage renal failure

被引:24
|
作者
Dahaba, AA
von Klobucar, F
Rehak, PH
List, WF
机构
[1] Karl Franzens Univ Graz, Dept Anesthesiol & Intens Care Med, Graz, Austria
[2] Karl Franzens Univ Graz, Dept Surg, Biomed Engn & Comp Unit, Graz, Austria
关键词
D O I
10.1007/BF03013962
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose: To compare recovery parameters of total intravenous anesthesia (TIVA) with remifentanil and propofol, hemodynamic responses to perioperative events, and pharmacodynamic parameters of cisatracurium in 22 end-stage renal failure and 22 normal renal function patients. Methods: Anesthesia was induced with 2-3 mg.kg(-1) propofol and 1 mu g.kg(-1) remifentanil and maintained with 75 mu g.kg(-1).min(-1) propofol and propofol initial infusion of 0.2 mu g.kg(-1).min(-1) propofol. Arterial pressure and heart rate were maintained by remifentanil infusion rate adjustments. The first twitch (TI) was maintained at 25% by an infusion-of cisatracurium. Results: There was no difference in the time to maintenance of adequate respiration, date of birth recollection, first analgesic administration, between the renal failure (4.8 +/- 2.5, 7.8 +/- 3.2, 12.3 +/- 5.3 min respectively) and the control group (5.2 +/- 2.8, 8.1 +/- 3.1, 12.7 +/- 5.5 min): nor were there any differences in the time to 25% TI recovery, TI recovery from 25% to 75%, or cisatracurium infusion rate between the renal failure group (32.1 +/- 10.8 min, 18.2 +/- 5.5 min; 0.89 +/- 0.29 mu g.kg(-1).min(-1) respectively) and the control group (35.9 (7.9 min, 18.4 +/- 3.8 min, 0.95 +/- 0.22 mu g.kg(-1).min(-1)). Conclusion: End-stage renal failure does not prolong recovery from TIVA with remifentanil and propofol, or the recovery from cisatracurium neuromuscular block.
引用
收藏
页码:696 / 700
页数:5
相关论文
共 50 条
  • [1] Total intravenous anesthesia with remifentanil, propofol and cisatracurium in end-stage renal failure
    Ashraf A. Dahaba
    Fedor von Klobucar
    Peter H. Rehak
    Werner F. List
    Canadian Journal of Anesthesia, 1999, 46 : 696 - 700
  • [2] Total intravenous anesthesia with midazolam, remifentanil, propofol and cisatracurium in morbid obesity
    Alvarez, AO
    Cascardo, A
    Menendez, SA
    Capria, JJ
    Cordero, RA
    OBESITY SURGERY, 2000, 10 (04) : 353 - 360
  • [3] Total Intravenous Anesthesia with Midazolam, Remifentanil, Propofol and Cisatracurium in Morbid Obesity
    Adrián Osvaldo Alvarez
    Antonio Cascardo
    Silvio Albarracin Menendez
    Juan José Capria
    Rafael Alvarez Cordero
    Obesity Surgery, 2000, 10 : 353 - 360
  • [4] Comparison of hepatic and renal function between inhalation anesthesia with sevoflurane and remifentanil and total intravenous anesthesia with propofol and remifentanil for thyroidectomy
    Kim, Ji Wook
    Kim, Joo Duck
    Yu, Soo Bong
    Ryu, Sie Jeong
    KOREAN JOURNAL OF ANESTHESIOLOGY, 2013, 64 (02) : 112 - 116
  • [5] Propofol and remifentanil total intravenous anesthesia for a patient with Huntington disease
    MacPherson, P
    Harper, I
    MacDonald, I
    JOURNAL OF CLINICAL ANESTHESIA, 2004, 16 (07) : 537 - 538
  • [6] Total intravenous anesthesia with propofol and remifentanil in a patient with MELAS syndrome
    Park, Jin Suk
    Baek, Chong Wha
    Kang, Hyun
    Cha, Su Man
    Park, Jung Won
    Jung, Yong Hun
    Woo, Young-Cheol
    KOREAN JOURNAL OF ANESTHESIOLOGY, 2010, 58 (04) : 409 - 412
  • [7] The influence of propofol-based total intravenous anesthesia on postoperative outcomes in end-stage renal disease patients: A retrospective observation study
    Cho, Ho Bum
    Kim, Mun Gyu
    Park, Sun Young
    Song, Sanghoon
    Jang, Youn Sil
    Park, Suyeon
    Lee, Hyun Keun
    Yoo, Jae Hwa
    Chung, Ji Won
    Kim, Sang Ho
    PLOS ONE, 2021, 16 (07):
  • [8] Recovery of psychomotor function after total intravenous anesthesia with remifentanil–propofol or fentanyl–propofol
    Aki Takayama
    Shigeki Yamaguchi
    Kazuyoshi Ishikawa
    Mio Shinozaki
    Yoshiyuki Kimura
    Masaru Nagao
    Toshimitsu Kitajima
    Journal of Anesthesia, 2012, 26 : 34 - 38
  • [9] End-stage renal failure
    Mason, RG
    JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 2002, 122 (04): : 269 - 269
  • [10] End-stage renal failure due to total uterine prolapse
    Sanai, T
    Yamashro, Y
    Nakayama, M
    Uesugi, N
    Kubo, N
    Iguchi, A
    UROLOGY, 2006, 67 (03) : 622.e5 - 622.e7